Samsung Biologics(207940.KS)
Incheon, South KoreaCDMO (Contract Manufacturing)
Focus: Samsung Biologics is a Contract Development and Manufacturing Organization (CDMO) headquartered in Incheon, South Korea, serving global biopharmaceutical clients. The company operates at significant scale with 5,001–10,000 employees and is a publicly traded entity on the Korean stock exchange.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5001-10000
Open Jobs
0
About Samsung Biologics
AI assessmentNot HiringNo open roles listed right now. Follow Samsung Biologics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Samsung Biologics(1)
Help build intelligence for Samsung Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.